Chelation therapy for secondary neonatal iron over load: Lessons learned from rhesus hemolytic disease

Secondary neonatal iron overload occurs with intrauterine and post-natal bloodtransfusions. Treatment with intravenous Deferoxamine was reported only infour cases in the literature. Herein we report a case of a patient born at 36weeks of gestation, who had rhesus hemolytic disease. He developed secondaryiron overload, causing liver injury, after a total of six blood transfusions: fourintrauterine and 2 post-natal transfusion therapies. Intravenous Deferoxaminetreatment was started at the age of 45 days due to a ferritin level of 40,000mg/L, progressive rise of liver enzymes, and worsening cholestasis. Treatmentresulted in marked reduction in ferritin level (down to 829 mg/L at the ageof 6 months), significant improvement in the liver enzymes, and resolutionof cholestasis

___

1. Aygun C, Tekinalp G, Gurgey A. Increased fetal iron load in rhesus hemolytic disease. Pediatr Hematol Oncol 2004; 21: 329-333.

2. Craparo FJ, Bonati F, Gementi P, Nicolini U. The effects of serial intravascular transfusions in ascitic/ hydropic RhD-alloimmunized fetuses. Ultrasound Obstet Gynecol 2005; 25: 144-148.

3. Smits-Wintjens VE, Rath ME, Lindenburg IT, et al. Cholestasis in neonates with red cell alloimmune hemolytic disease: Incidence, risk factors and outcome. Neonatology 2012; 101: 306-310.

4. FBadran E, Al-lawama M, Masri A, Al-Amouri I, Al Kazaleh F. Fetal intrauterine transfusion therapy: Neonatal outcomes. J Blood Lymph 2013; 3: 112.

5. Demircioglu F, Caglayan Sozmen S, Yilmaz S, et al. Severe iron overload and hyporegenerative anemia in a case with rhesus hemolytic disease: therapeutic approach to rare complications. Turk J Haematol 2010; 27: 204-208.

6. Sreenan C, Idikio HA, Osiovich H. Successful chelation therapy in a case of neonatal iron overload following intravascular intrauterine transfusion. J Perinatol 2000; 20: 509-512.

7. Yilmaz S, Duman N, Ozer E, et al. A case of rhesus hemolytic disease with hemophagocytosis and severe iron overload due to multiple transfusions. J Pediatr Hematol Oncol 2006; 28: 290-292.

8. Yalaz M, Bilgin BS, Koroglu OA, et al. Desferrioxamine treatment of iron overload secondary to RH isoimmunization and intrauterine transfusion in a newborn infant. Eur J Pediatr 2011; 170: 1457-1460.

9. Fawaz R, Baumann U, Ekong U, et al. Guideline for the Evaluation of Cholestatic Jaundice in Infants: Joint Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr 2017; 64 :154-168.

10. Feldman AG, Whitington PF. Neonatal hemochromatosis. J Clin Exp Hepatol 2013; 3: 313-320.

11. Botzenhardt S, Li N, Chan EW, Sing CW, Wong IC, Neubert A. Safety profiles of iron chelators in young patients with haemoglobinopathies. Eur J Haematol 2017; 98: 198-217.

12. Mobarra N, Shanaki M, Ehteram H, et al. A Review on Iron Chelators in Treatment of Iron Overload Syndromes. Int J Hematol Oncol Stem Cell Res 2016; 10: 239-247.

13. Taher AT, Porter JB, Kattamis A, Viprakasit V, Cappellini MD. Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with nontransfusiondependent thalassemia syndromes. Drug Des Devel Ther 2016; 10: 4073-4078.

14. Thorp JA, O'Connor T, Callenbach J, et al. Hyporegenerative anemia associated with intrauterine transfusion in rhesus hemolytic disease. Am J Obstet Gynecol 1991; 165: 79-8
Turkish Journal of Pediatrics-Cover
  • ISSN: 0041-4301
  • Yayın Aralığı: Yılda 6 Sayı
  • Başlangıç: 1958
  • Yayıncı: Hacettepe Üniversitesi Çocuk Sağlığı Enstitüsü Müdürlüğü
Sayıdaki Diğer Makaleler

High alert medications administration errors in neonatal intensive care unit: A pediatric tertiary hospital experience

John Rene LABIB, Meray Rene Labib YOUSSEF, Shaimaa A. M. Abd El FATAH

A case of steroid-resistance Hashimoto's encephalopathy presenting with sensorimotor polyneuropathy

Hüseyin ÇAKSEN, Serhat EMEKSİZ, Nurettin Onur KUTLU, Nuri ALAÇAKIR

The influence of media on the sleep quality in adolescents

Duygu AKÇAY, Bülent Devrim AKÇAY

GPR56 homozygous nonsense mutation p.R271* associated with phenotypic variability in bilateral frontoparietal polymicrogyria

Tülay ÖNCÜ ÖNER, Aycan ÜNALP, lknur PORSUK DORU, Sinem AĞILKAYA, Handan GÜLERYÜZ, Sultan CİNGÖZ, Aydan SARAÇ, Bekir ERGÜNER, Bayram YÜKSEL, Semra HIZ KURUL

Gelsolin levels in patients with bronchiolitis

Feyza HÜSREVOĞLU ESEN, Yasemin ALTUNER TORUN, Çiğdem KARAKÜKCÜ, Seçil KÖSE, Ahmet ŞEHRİYAROĞLU, Dilek KAFADAR, Aydın ESEN, Mehmet KÖSE

Glycemic control and health behaviors in adolescents with type 1 diabetes

Oya ERCAN, Müjgan ALİKAŞİFOĞLU, Kayı ELİAÇIK, Aylin YETİM, Gülnaz ÇIĞ, Firdevs BAŞ, Ethem ERGİNÖZ, Rüveyde BUNDAK

A case of steroid-resistance Hashimoto's encephalopathy presenting with sensorimotor polyneuropathy

SERHAT EMEKSİZ, Nurettin Onur KUTLU, Nuri ALAÇAKIR, HÜSEYİN ÇAKSEN

An infant case of renovascular hypertension in moyamoya disease treated by angioplasty

Jianming GUO, Lianrui GUO, Gao ZENG, Zhu TONG, Xixiang GAO, Yongquan GU

Arrhythmia in thiamine responsive megaloblastic anemia syndrome

Mustafa ARGUN, Ali BAYKAN, Nihal HATİPOĞLU, Leyla AKIN, Yavuz ŞAHİN, Nazmi NARİN, Selim KURTOĞLU

Birth outcomes after inadvertent use of category X drugs contraindicated in pregnancy: Where is the real risk?

Zeynep ÖZTÜRK, ERCÜMENT ÖLMEZ, Tuğba GÜRPINAR, KAMİL VURAL